Cargando…

Association Between Blunted Glomerular Hyperfiltration in Pregnancy and Severe Maternal Morbidity—A Research Letter

BACKGROUND: Glomerular hyperfiltration is one physiological adaptation to pregnancy, marked by a decline in serum creatinine (SCr) concentration by 16 weeks’ gestation. It is not known whether blunted glomerular hyperfiltration leads to adverse maternal outcomes, including severe maternal morbidity...

Descripción completa

Detalles Bibliográficos
Autores principales: Harel, Ziv, Park, Alison L., Ray, Joel G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552384/
https://www.ncbi.nlm.nih.gov/pubmed/34721883
http://dx.doi.org/10.1177/20543581211035221
_version_ 1784591365058854912
author Harel, Ziv
Park, Alison L.
Ray, Joel G.
author_facet Harel, Ziv
Park, Alison L.
Ray, Joel G.
author_sort Harel, Ziv
collection PubMed
description BACKGROUND: Glomerular hyperfiltration is one physiological adaptation to pregnancy, marked by a decline in serum creatinine (SCr) concentration by 16 weeks’ gestation. It is not known whether blunted glomerular hyperfiltration leads to adverse maternal outcomes, including severe maternal morbidity (SMM). OBJECTIVE: To evaluate the association between blunted glomerular hyperfiltration and subsequent SMM or death. DESIGN: Population-based cohort study SETTING: Ontario, Canada, from 2008 to 2019. PARTICIPANTS: Included were births among women who had ≥ 1 SCr measured as an outpatient within 10 weeks before conception (“preconception”), and again, at 11(0/7) to 20(6/7) weeks’ gestation (“in-pregnancy”). Excluded were women who died before birth, who had end-stage renal disease or kidney transplantation before conception, or whose pre-pregnancy SCr was 125 μmol/L. EXPOSURE: Net glomerular hyperfiltration defined as the preconception minus the in-pregnancy SCr. MEASURES: The primary study outcome was SMM or death arising from 23 weeks’ gestation up to 42 days after the index birth. METHODS: Adjusted relative risks (aRRs) were calculated using Modified Poisson regression per 1-SD net blunting of glomerular hyperfiltration adjusting for important covariates. RESULTS: A total of 10,323 births met all inclusion criteria. The mean (SD) SCr was 61.7 (11.0) μmol/L preconception, 48.0 (9.2) μmol/L in-pregnancy, and the mean net difference 13.6 (8.2) μmol/L. Among these births, the adjusted RR of SMM or death from 23 weeks’ gestation up to 42 days post-partum was 1.16 (95% confidence interval 1.14-1.30) per 1-SD (8.2 μmol/L) net blunting of glomerular hyperfiltration. LIMITATIONS: As SCr assessment is not a routine part of pregnancy care, its measurement could have been for a specific health condition thereby imparting selection bias. CONCLUSIONS: Blunted glomerular hyperfiltration in pregnancy may identify some women at higher risk of SMM. Further prospective research is needed about the implications of glomerular hyperfiltration in early pregnancy.
format Online
Article
Text
id pubmed-8552384
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-85523842021-10-29 Association Between Blunted Glomerular Hyperfiltration in Pregnancy and Severe Maternal Morbidity—A Research Letter Harel, Ziv Park, Alison L. Ray, Joel G. Can J Kidney Health Dis Clinical Research Letter BACKGROUND: Glomerular hyperfiltration is one physiological adaptation to pregnancy, marked by a decline in serum creatinine (SCr) concentration by 16 weeks’ gestation. It is not known whether blunted glomerular hyperfiltration leads to adverse maternal outcomes, including severe maternal morbidity (SMM). OBJECTIVE: To evaluate the association between blunted glomerular hyperfiltration and subsequent SMM or death. DESIGN: Population-based cohort study SETTING: Ontario, Canada, from 2008 to 2019. PARTICIPANTS: Included were births among women who had ≥ 1 SCr measured as an outpatient within 10 weeks before conception (“preconception”), and again, at 11(0/7) to 20(6/7) weeks’ gestation (“in-pregnancy”). Excluded were women who died before birth, who had end-stage renal disease or kidney transplantation before conception, or whose pre-pregnancy SCr was 125 μmol/L. EXPOSURE: Net glomerular hyperfiltration defined as the preconception minus the in-pregnancy SCr. MEASURES: The primary study outcome was SMM or death arising from 23 weeks’ gestation up to 42 days after the index birth. METHODS: Adjusted relative risks (aRRs) were calculated using Modified Poisson regression per 1-SD net blunting of glomerular hyperfiltration adjusting for important covariates. RESULTS: A total of 10,323 births met all inclusion criteria. The mean (SD) SCr was 61.7 (11.0) μmol/L preconception, 48.0 (9.2) μmol/L in-pregnancy, and the mean net difference 13.6 (8.2) μmol/L. Among these births, the adjusted RR of SMM or death from 23 weeks’ gestation up to 42 days post-partum was 1.16 (95% confidence interval 1.14-1.30) per 1-SD (8.2 μmol/L) net blunting of glomerular hyperfiltration. LIMITATIONS: As SCr assessment is not a routine part of pregnancy care, its measurement could have been for a specific health condition thereby imparting selection bias. CONCLUSIONS: Blunted glomerular hyperfiltration in pregnancy may identify some women at higher risk of SMM. Further prospective research is needed about the implications of glomerular hyperfiltration in early pregnancy. SAGE Publications 2021-10-26 /pmc/articles/PMC8552384/ /pubmed/34721883 http://dx.doi.org/10.1177/20543581211035221 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Clinical Research Letter
Harel, Ziv
Park, Alison L.
Ray, Joel G.
Association Between Blunted Glomerular Hyperfiltration in Pregnancy and Severe Maternal Morbidity—A Research Letter
title Association Between Blunted Glomerular Hyperfiltration in Pregnancy and Severe Maternal Morbidity—A Research Letter
title_full Association Between Blunted Glomerular Hyperfiltration in Pregnancy and Severe Maternal Morbidity—A Research Letter
title_fullStr Association Between Blunted Glomerular Hyperfiltration in Pregnancy and Severe Maternal Morbidity—A Research Letter
title_full_unstemmed Association Between Blunted Glomerular Hyperfiltration in Pregnancy and Severe Maternal Morbidity—A Research Letter
title_short Association Between Blunted Glomerular Hyperfiltration in Pregnancy and Severe Maternal Morbidity—A Research Letter
title_sort association between blunted glomerular hyperfiltration in pregnancy and severe maternal morbidity—a research letter
topic Clinical Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552384/
https://www.ncbi.nlm.nih.gov/pubmed/34721883
http://dx.doi.org/10.1177/20543581211035221
work_keys_str_mv AT harelziv associationbetweenbluntedglomerularhyperfiltrationinpregnancyandseverematernalmorbidityaresearchletter
AT parkalisonl associationbetweenbluntedglomerularhyperfiltrationinpregnancyandseverematernalmorbidityaresearchletter
AT rayjoelg associationbetweenbluntedglomerularhyperfiltrationinpregnancyandseverematernalmorbidityaresearchletter